A detailed history of Momentum Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Momentum Advisors, LLC holds 8,662 shares of MRNA stock, worth $319,194. This represents 1.61% of its overall portfolio holdings.

Number of Shares
8,662
Previous 8,690 0.32%
Holding current value
$319,194
Previous $1.03 Million 51.26%
% of portfolio
1.61%
Previous 1.14%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$118.38 - $210.04 $3,314 - $5,881
-28 Reduced 0.32%
8,662 $1.56 Million
Q3 2022

Nov 10, 2022

BUY
$118.07 - $194.18 $25,857 - $42,525
219 Added 2.59%
8,690 $1.03 Million
Q2 2022

Jul 22, 2022

BUY
$117.13 - $176.59 $992,208 - $1.5 Million
8,471 New
8,471 $1.21 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Momentum Advisors, LLC Portfolio

Follow Momentum Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Momentum Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Momentum Advisors, LLC with notifications on news.